Obesity Explained
Since 1960, American adults have, on average, gained 28 pounds. That’s the…
Changing Fortunes in the Obesity Treatment Industry
With Qnexa, Contrave and Lorcaserin each recently rejuvenated after previous FDA's near-death…
The Truth About Healthcare Around the World
According to Reuters, “The United States spends more on healthcare than any…
European Obesity Drug and Device Markets
Arguably, the biggest threat in the field of healthcare is the looming…
Is The FDA Keeping Us Fat?
Two-thirds of Americans are overweight or obese. A Gallup poll found that…
Diabetes Doubles Risk of Dementia, Alzheimer’s
A study on the relationship between diabetes and dementia reveals that diabetes…
FDA Accepts NDA for VIVUS’ Qnexa
VIVUS, Inc., has announced that the FDA has accepted its new drug…
Weight Loss Surgery – An Acceptable Alternative Treatment for Obesity
According to the California Health Care Foundation which publishes California Healthline,…
European Obesity Market on Track to Show Drug, Device Gains
The FDA put a slight dent in forecasts for obesity drugs, with…